sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Microbiome Therapeutics Market...

欧洲微生物组治疗市场预测至 2030 年 - 区域分析 - 按类型（治疗和手术）、应用（代谢紊乱和肥胖、艰难梭菌感染、炎症性肠病等）和最终用户（医院和诊所、门诊手术中心） 、家庭护理和其他）

BMIRE00029955 | Pages: 71 | Pharmaceuticals | Apr 2024 | Type: Regional | Status: Published
2022年欧洲微生物组治疗市场价值为9774万美元，预计到2030年将达到2.1252亿美元；据估计，从 2022 年到 2030 年，复合年增长率将达到 10.2%。改善微生物组发现管道的资金流入推动欧洲微生物组治疗市场 研究表明，微生物组的不平衡或破坏可能导致各种疾病，例如炎症性肠病和肥胖，以及精神健康障碍。微生物组在整体健康中的作用的认识引起了人们对开发针对和调节微生物组的疗法的浓厚兴趣。此外，技术和研究工具的进步使得研究和操纵微生物组变得更加容易。新一代测序和宏基因组分析使人们能够更深入地了解微生物群落及其功能。知识的增加为开发靶向疗法开辟了新的可能性。例如，2023 年 3 月，德国微生物组生物技术公司 mbiomics GmbH 开发了第一代有效的基于微生物组的疗法。它从 MIG Capital 获得了 1300 万美元（1500 万美元）的融资。这笔资金将用于建立该平台，这将加速第一批候选药物的识别，并加快临床验证的研究工作。随着强有力的临床证据的出现，投资者开始注意到微生物组调节剂公司。增加的资金为公司提供了必要的资源，以克服与开发和生产高成本相关的挑战，最终推动该领域向前发展。欧洲微生物组治疗市场概述 德国微生物组治疗研究公司致力于呼吁其他公司投资其研究活动，以提高微生物组产品开发研究的质量。 2023 年 3 月，专注于微生物组的德国生物技术公司 mbiomics GmbH 在 MIG Capital 领投的 A 轮融资中获得约 1500 万美元（1300 万美元）。 mbiomics 利用所得收益建立了战略合作伙伴关系，显着扩大了其在德国的慕尼黑实验室设施和研发团队。在一些 FMT 程序中，传染源可能会从捐赠者转移到患者身上，从而影响结果。因此，德国对微生物组或 FMT 程序的使用制定了特殊规定。在德国，FMT 药物作为药品进行监管；然而，只有当其他治疗方法对艰难梭菌感染和肠道感染等病症无效时，才能使用该产品。因此，尽管微生物组治疗研究的投资激增，但有关这些治疗产品使用的法规可能会阻碍德国欧洲微生物组治疗市场的增长。欧洲微生物组治疗市场收入和预测到 2030 年（百万美元） 欧洲微生物组治疗市场细分 欧洲微生物组治疗市场根据类型、应用、最终用户和国家进行细分。根据类型，欧洲微生物组治疗市场分为治疗方法和手术方法。到 2022 年，手术细分市场将占据更大份额。治疗细分市场进一步细分为粪便微生物群移植 (FMT)、益生元和益生菌等。根据应用，欧洲微生物组治疗市场分为代谢紊乱和肥胖、艰难梭菌感染、炎症性肠病等。 2022 年，代谢紊乱和肥胖细分市场占据最大份额。按最终用户划分，欧洲微生物组治疗市场包括医院和诊所、门诊手术中心、家庭护理等。 2022 年，医院和诊所细分市场占据最大份额。根据国家/地区，欧洲微生物组治疗市场分为英国、德国、法国、意大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲微生物组治疗市场占据主导地位。Caelus Health BV、Enterome SA、Ferring Holdings SA、Vedanta Biosciences Inc 和 YSOPIA Bioscience SA 是欧洲微生物组治疗市场的一些领先公司。
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Microbiome Therapeutics Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

5. Europe Microbiome Therapeutics Market - Key Industry Dynamics

5.1 Europe Microbiome Therapeutics Market - Key Industry Dynamics

5.2 Key Market Drivers

5.2.1 Potential of Gut Microbiota in Maintaining Human Health

5.2.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline

5.3 Key Market Restraints

5.3.1 High Cost of Development and Production

5.4 Key Market Opportunities

5.4.1 Increasing R&D to Gain Better Understanding of Human Microbiome

5.5 Key Future Trends

5.5.1 Technological Advancement in Human Microbiome Therapeutics

5.6 Impact of Drivers and Restraints:

6. Microbiome Therapeutics Market - Europe Market Analysis

7. Europe Microbiome Therapeutics Market Analysis - Type

7.1 Therapeutics

7.1.1 Overview

7.1.2 Therapeutics Market, Revenue and Forecast to 2030 (US$ Thousand)

7.2 Procedure

7.2.1 Overview

7.2.2 Procedure Market, Revenue and Forecast to 2030 (US$ Thousand)

8. Europe Microbiome Therapeutics Market Analysis - Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview

8.1.2 Metabolic Disorder and Obesity Market, Revenue and Forecast to 2030 (US$ Thousand)

8.2 C. Difficile Infection (CDI)

8.2.1 Overview

8.2.2 C. Difficile Infection (CDI) Market, Revenue and Forecast to 2030 (US$ Thousand)

8.3 Inflammatory Bowel Disease

8.3.1 Overview

8.3.2 Inflammatory Bowel Disease Market, Revenue and Forecast to 2030 (US$ Thousand)

8.4 Others

8.4.1 Overview

8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

9. Europe Microbiome Therapeutics Market Analysis - End User

9.1 Hospitals and Clinics

9.1.1 Overview

9.1.2 Hospitals and Clinics Market, Revenue and Forecast to 2030 (US$ Thousand)

9.2 Ambulatory Surgical Centers

9.2.1 Overview

9.2.2 Ambulatory Surgical Centers Market, Revenue and Forecast to 2030 (US$ Thousand)

9.3 Homecare

9.3.1 Overview

9.3.2 Homecare Market, Revenue and Forecast to 2030 (US$ Thousand)

9.4 Others

9.4.1 Overview

9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

10. Europe Microbiome Therapeutics Market - Country Analysis

10.1. Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.1 Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.2 UK

10.1.2.1 UK: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.2.2 United Kingdom Europe Microbiome Therapeutics Market Breakdown by Type

10.1.2.2.1 UK: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.2.3 UK: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.2.4 UK: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.3 Germany

10.1.3.1 Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.3.2 Germany: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.3.2.1 Germany: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.3.3 Germany: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.3.4 Germany: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.4 France

10.1.4.1 France: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.4.2 France: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.4.2.1 France: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.4.3 France: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.4.4 France: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.5 Italy

10.1.5.1 Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.5.2 Italy: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.5.2.1 Italy: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.5.3 Italy: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.5.4 Italy: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.6 Spain

10.1.6.1 Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.6.2 Spain: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.6.2.1 Spain: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.6.3 Spain: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.6.4 Spain: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.7 Rest of Europe

10.1.7.1 Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.7.2 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.7.2.1 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.7.3 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.7.4 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Europe Microbiome Therapeutics Market

12. Company Profiles

12.1 YSOPIA Bioscience SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Ferring Holdings SA

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Enterome SA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Caelus Health BV

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Vedanta Biosciences Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Europe Microbiome Therapeutics Market Segmentation

Table 2. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Type

Table 3. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Therapeutics

Table 4. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Application

Table 5. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - End User

Table 6. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Country

Table 7. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 8. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 9. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 10. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 11. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 12. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 13. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 14. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 15. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 16. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 17. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 18. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 19. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 20. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 21. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 22. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 23. ADULT OBESITY, 2030

Table 24. CHILD OBESITY, 2030

Table 25. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 26. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 27. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 28. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 29. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 30. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 31. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 32. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 33. Recent Growth Strategies in Europe Microbiome Therapeutics Market

Table 34. Glossary of Terms, Europe Microbiome Therapeutics Market

List of Figures

Figure 1. Europe Microbiome Therapeutics Market Segmentation, By Country

Figure 2. Europe PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Microbiome Therapeutics Market Revenue (US$ Thousand), 2022 - 2030

Figure 5. Europe Microbiome Therapeutics Market Share (%) - Type, 2022 and 2030

Figure 6. Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 7. Procedure Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 8. Europe Microbiome Therapeutics Market Share (%) - Application, 2022 and 2030

Figure 9. Metabolic Disorder and Obesity Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 10. C. Difficile Infection (CDI) Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 11. Inflammatory Bowel Disease Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 12. Others Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 13. Europe Microbiome Therapeutics Market Share (%) - End User, 2022 and 2030

Figure 14. Hospitals and Clinics Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 15. Ambulatory Surgical Centers Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 16. Homecare Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 17. Others Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 18. Europe Microbiome Therapeutics Market Breakdown by Key Countries - Revenue (2022) (US$ Thousand)

Figure 19. Europe Microbiome Therapeutics Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 20. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 21. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 22. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 23. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 24. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 25. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

1. Caelus Health BV

2. Enterome SA

3. Ferring Holdings SA

4. Vedanta Biosciences Inc

5. YSOPIA Bioscience SA

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe microbiome therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe microbiome therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the microbiome therapeutics market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
    • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports
    Report Name Published Date
    Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
    Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
    Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440
    GET FREE SAMPLE PDF
    Inquire before Buying Inquire for Discount
    Subscription Member Price: FREE
    Get Subscription